Company
United StatesPublic company, NASDAQ: PTCTPTC Therapeutics, Inc. (NASDAQ: PTCT), Warren, NJ – FDA Inspections
Inspection records and compliance data for PTC Therapeutics, Inc. in Warren, New Jersey. 4 FDA inspections on record, 1 Form 483, last inspected May 22, 2025. Publicly traded as NASDAQ: PTCT.
Company Profile
This profile covers PTC Therapeutics, Inc. based in Warren, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 1
- NAI
- 3
- Form 483s
- 1
- Warning letters
- 0
First inspected August 8, 2017. Last inspected May 22, 2025.
Most cited issue areas
- General responsibilities of sponsors1 inspection
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 22, 2025 | NAI | Human Drugs · Bioresearch Monitoring | 1271557 |
| November 18, 2024 | VAI | Human Drugs · Bioresearch Monitoring: Human Drugs | 1254452 |
| August 12, 2020 | NAI | Human Drugs · Bioresearch Monitoring | 1128908 |
| August 8, 2017 | NAI | Human Drugs · Bioresearch Monitoring | 1024973 |
FDA documents
Form 483s (1)
Other FDA documents (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
PTC Therapeutics, Inc.
Stock ticker
PTCT
Exchange
NASDAQ
Share price
$63.36
Market cap
$5.3B
Price as of
November 13, 2026
FEI Number
3003425888
Address
500 Warren Corporate Center Drive, Warren, New Jersey 07059, United States
Country
United States
ID: 7121dadc-2bde-46a2-bf7f-1b7b40da4b6d